These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6567529)

  • 21. The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure: a prospective, randomized, controlled prevention trial of the German Hypertension League.
    Lüders S; Schrader J; Berger J; Unger T; Zidek W; Böhm M; Middeke M; Motz W; Lübcke C; Gansz A; Brokamp L; Schmieder RE; Trenkwalder P; Haller H; Dominiak P;
    J Hypertens; 2008 Jul; 26(7):1487-96. PubMed ID: 18551027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beta-blockers for primary prevention in hypertension: era bygone?
    Panjrath GS; Messerli FH
    Prog Cardiovasc Dis; 2006; 49(2):76-87. PubMed ID: 17046433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The use of coronary risk charts].
    Menotti A; Puddu PE; Lanti M
    G Ital Cardiol; 1999 Sep; 29(9):1004-6. PubMed ID: 10514957
    [No Abstract]   [Full Text] [Related]  

  • 24. Implications of small reductions in diastolic blood pressure for primary prevention.
    Cook NR; Cohen J; Hebert PR; Taylor JO; Hennekens CH
    Arch Intern Med; 1995 Apr; 155(7):701-9. PubMed ID: 7695458
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention and treatment of essential hypertension and coronary heart disease in factories.
    Chin Med J (Engl); 1977 May; 3(3):157-62. PubMed ID: 410599
    [No Abstract]   [Full Text] [Related]  

  • 26. [Prevention of coronary disease in clinical practice. Guidelines of the working group of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension].
    Pyörälä K; de Backer G; Graham I; Poole-Wilson P; Wood D
    Arch Mal Coeur Vaiss; 1995 Oct; 88(10 Suppl):1493-542. PubMed ID: 8815824
    [No Abstract]   [Full Text] [Related]  

  • 27. [Primary prevention of ischemic heart disease. A review on the intervention survey].
    Brendstrup T; Mørck HI
    Ugeskr Laeger; 1980 Jan; 142(3):191-6. PubMed ID: 7355497
    [No Abstract]   [Full Text] [Related]  

  • 28. Salt intake and hypertension therapy.
    Milan A; Mulatero P; Rabbia F; Veglio F
    J Nephrol; 2002; 15(1):1-6. PubMed ID: 11936420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The effect of beta-receptor antagonists and diuretics and their combination on blood pressure and pressure-rate product during ergometric work in hypertensive patients (author's transl)].
    Franz IW
    Z Kardiol; 1982 Jan; 71(2):129-37. PubMed ID: 7072313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blood pressure reduction is not the only determinant of outcome.
    Sever PS; Poulter NR; Elliott WJ; Jonsson MC; Black HR; Sever PS; Poulter NR; Elliott WJ; Jonsson MC; Black HR
    Circulation; 2006 Jun; 113(23):2754-72; discussion 2773-4. PubMed ID: 16769926
    [No Abstract]   [Full Text] [Related]  

  • 31. [Hypertension at the threshold of the year 2000: classification, treatment, prevention].
    Morici ML; Di Marco A
    Recenti Prog Med; 1994 Apr; 85(4):246-56. PubMed ID: 8016451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood pressure, diabetes and diabetic nephropathy.
    Chantrel F; Moulin B; Hannedouche T
    Diabetes Metab; 2000 Jul; 26 Suppl 4():37-44. PubMed ID: 10922972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lifestyle modifications to prevent and control hypertension. 2. Recommendations on obesity and weight loss. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.
    Leiter LA; Abbott D; Campbell NR; Mendelson R; Ogilvie RI; Chockalingam A
    CMAJ; 1999 May; 160(9 Suppl):S7-12. PubMed ID: 10333848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypertension treatment and the prevention of coronary heart disease in the elderly.
    Moser M
    Am Fam Physician; 1999 Mar; 59(5):1248-56. PubMed ID: 10088879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary and secondary prevention of cardiovascular disease in the elderly.
    García-Palmieri MR
    Bol Asoc Med P R; 2000; 92(1-3):3-8. PubMed ID: 10846280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of hypertension and primary prevention of coronary heart disease. Proceedings of a satellite symposium. Geneva, 25 April 1985.
    Drugs; 1986; 31 Suppl 1():1-73. PubMed ID: 3720568
    [No Abstract]   [Full Text] [Related]  

  • 37. [Prevention of coronary disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology (ESC), European Atherosclerosis Society (EAS) and European Society of Hypertension (ESH)].
    de Backer G; Graham I; Poole-Wilson P; Pyörälä K; Shepherd J; Wood D; Zanchetti A
    Rev Esp Cardiol; 1995 Dec; 48(12):773-80. PubMed ID: 8685497
    [No Abstract]   [Full Text] [Related]  

  • 38. The management of mild hypertension: a review of relevant studies.
    Alderman MH
    Trans Assoc Life Insur Med Dir Am; 1980; 64():130-45. PubMed ID: 7331173
    [No Abstract]   [Full Text] [Related]  

  • 39. [Results of 2 years of primary and secondary prevention of arterial hypertension in women in an organized population].
    Eliseeva NA
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1984; 7(2):100-1. PubMed ID: 6508918
    [No Abstract]   [Full Text] [Related]  

  • 40. Prevention of coronary artery disease.
    N Engl J Med; 1991 Jul; 325(3):203-5. PubMed ID: 2052065
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.